Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAMe vs Pentoxiphylline in NASH with Fibrosis
NCT02231333Completed
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Jul 2013
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of S-adenosylmethionine in Nonalcoholic steatohepatitis (NASH), sponsored by Institute of Liver and Biliary Sciences. Primary endpoint: Biochemical improvement in AST/ALT at 1 year. Started Jul 2013; status: completed.
02
Drugs
S-adenosylmethionine
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT02231333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02231333.